Latest: FDA Approves New Biosimilar for Oncology Treatment

Citizen Health Secures $30M to Pioneer AI-Powered Rare Disease Care

0 Mins
What You Should Know: – San Francisco-based Citizen Health, a platform empowering patients with rare and complex conditions, secures $30M in Series A funding led by 8VC, with participation from Transformation Capital and Headline, bringing the company’s total funding to $44M since its launch in late 2023. – The new capital will accelerate the development ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago